MDMA: party drugs as medicine in Australia

MDMA
Party drugs as medicine in Australia

Ecstasy tablets contain the active ingredient MDMA. photo

©Oliver Berg/dpa

Party drugs have recently been legalized in Australia for the treatment of depression and post-traumatic stress disorder. But there is criticism.

In Australia has been allowed to use the intoxicants ecstasy and magic mushrooms as medicinal products for therapeutic purposes since the beginning of the month. Down Under is the first country in the world to have approved party drugs as medicines.

The synthetic amphetamine derivative MDMA, a component of ecstasy, may be used to treat post-traumatic stress disorder (PTSD). The active substance psilocybin, which is contained in psychoactive mushrooms, is permitted for the treatment of otherwise untreatable depression. But experts are now sharply critical.

The critic

Leading psychologists and neuroscientists targeted the Australian Medicines Agency (TGA). She gave in to pressure from the public and lobby groups “to make these experimental treatments accessible outside of clinical trials,” according to an article published in the Australian & New Zealand Journal of Psychiatry. There is still insufficient evidence to justify a comprehensive approach, wrote the group led by Susan Rossell, cognitive neuropsychologist at Swinburne’s Center for Mental Health.

Although the first results of studies on the use of intoxicants are promising, many questions remain unanswered. The experts explained that treatment with MDMA or psilocybin must also be accompanied by psychotherapy. “Research in this regard is certainly still in its infancy.”

The Australian “Guardian” quoted a TGA spokesman as saying that the agency’s decision was in no way influenced by lobby groups or the media. The benefits of such treatment in some patients under the supervision of a licensed psychiatrist outweigh the possible disadvantages. For some treatment-resistant patients, the substances may be the only option, the TGA justified its decision in February.

Strict regulations apply to the granting of the necessary permission: Psychiatrists who want to use the active ingredients must obtain approval from the TGA after review and approval by an ethics committee.

What is MDMA?

MDMA induces euphoria in people. Neurotransmitters such as serotonin (also known as the “happiness hormone”) are released, which significantly lift the mood. Psilocybin is hallucinogenic and mind-expanding. Unlike other antidepressants, psilocybin does not dampen the emotional world, but rather intensifies emotions and sensory perceptions. However, experts warn of possible psychoses.

dpa

source site-1